Drug Delivery Aspects
Volume 4: Expectations and Realities of Multifunctional Drug Delivery Systems
- 1st Edition - March 27, 2020
- Latest edition
- Editor: Ranjita Shegokar
- Language: English
Drug Delivery Aspects reviews additional features of drug delivery systems, along with the standard formulation development, like preclinical testing, conversion into solid dos… Read more
Data Mining & ML
Unlock the cutting edge
Up to 20% on trusted resources. Build expertise with data mining, ML methods.
Description
Description
Drug Delivery Aspects reviews additional features of drug delivery systems, along with the standard formulation development, like preclinical testing, conversion into solid dosage forms, roles of excipients and polymers used on stability and sterile processing. There is a focus on formulation engineering and related large scale (GMP) manufacturing, regulatory, and functional aspects of drug delivery systems. A detailed discussion on biologics and vaccines gives insights to readers on new developments in this direction.
The series Expectations and Realities of Multifunctional Drug Delivery Systems examines the fabrication, optimization, biological aspects, regulatory and clinical success of wide range of drug delivery carriers. This series reviews multifunctionality and applications of drug delivery systems, industrial trends, regulatory challenges and in vivo success stories. Throughout the volumes discussions on diverse aspects of drug delivery carriers, such as clinical, engineering, and regulatory, facilitate insight sharing across expertise area and form a link for collaborations between industry-academic scientists and clinical researchers.
Expectations and Realities of Multifunctional Drug Delivery Systems connects formulation scientists, regulatory experts, engineers, clinical experts and regulatory stake holders. The wide scope of the book ensures it as a valuable reference resource for researchers in both academia and the pharmaceutical industry who want to learn more about drug delivery systems.
Key features
Key features
- Encompasses engineering and large-scale manufacturing of nanocarriers
- Considers preclinical, regulatory and ethical guidelines on nanoparticles
- Contains in-depth discussions on delivery of biologics, vaccines and sterilisation
- Industrial view on solid dispersions, milling techniques
Readership
Readership
Pharmaceutical Scientists in academia and industry; pharmacologists; regulatory experts; bioengineers
Table of contents
Table of contents
Mona M.A. Abdel-Mottaleb, Hend Abd-Allah, Riham I. El-Gogary, and Maha Nasr
2. Preclinical testing—Understanding the basics first
Ranjita Shegokar
3. Aqueous polymeric coatings: New opportunities in drug delivery systems
Abid Riaz Ahmed, Joana Portugal Mota, Ahmad Abdul-Wahhab Shahba, and Muhammad Irfan
4. Large-scale manufacturing of nanoparticles—An industrial outlook
Ranjita Shegokar and Mostafa Nakach
5. The role of polymers and excipients in developing amorphous solid dispersions: An industrial perspective
Vaibhav Sihorkar and Thomas Durig
6. Biologics: Delivery options and formulation development strategies
Ridahunlang Nongkhlaw, Parameswar Patra, Akash Chavrasiya, Nirmal Jayabalan, and Sachin Dubey
7. The regulatory and ethical issues in nanoparticles, materials and particles (NMP) research
J. Dias-Ferreira, Ranjita Shegokar, A. Santini, and E.B. Souto
8. Sterile procedures for pharmaceutical dosage forms
Sarabjit Singh and Dharmesh Mehta
9. Vaccine delivery strategies against botulism
Yongyong Yan, Diana Diaz-Arevalo, Haiyan Wang, Yanping Chen, and Mingtao Zeng
10. Nanotechnological approaches for delivery of antiinflammatory drugs
Anđelka B. Kovacevic
11. Food to medicine transformation of stilbenoid vesicular and lipid-based nanocarriers: Technological advances
Sara M. Abdel Samie and Maha Nasr
Product details
Product details
- Edition: 1
- Latest edition
- Published: March 27, 2020
- Language: English
About the editor
About the editor
RS
Ranjita Shegokar
Ranjita Shegokar holds a Ph.D. degree in Pharmaceutical Technology from the SNDT University, India, and has been a postdoctoral researcher in the Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics at the Free University of Berlin, Germany. Currently, she serves as Chief Scientific Officer (CSO) at Capnopharm GmbH, Germany. She has authored several research articles, book chapters, and presented her research in many national/international conferences. She has filed multiple patent applications in the area of drug delivery and targeting. Besides that, she has edited many trending books in the area of pharmaceutical nanotechnology and drug delivery aspects. For her research, she has received many prestigious national and international awards among them include recently received prestigious German Innovation Award 2022. Her areas of interest include polymeric nanoparticles, nanocrystals, lipid nanoparticles (SLNs/NLCs), nanoemulsions, cancer drug targeting and the role of excipients in delivery systems. (www.ranjitas.com)